Biomaterials Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Biomaterials Market
The biomaterials market size was valued at USD 110.0 billion in 2019, and the market is now projected to grow USD 420.6 billion by 2032, exhibiting a CAGR of 10.9% during the forecast period of 2020-2032.
COVID- 19 pandemic has extremely affected the complete world. It affected many unexpected disruption and affected the industry. The pandemic caused in declined demand due to a disturbed supply chain, drop in sales of products, delivery lists.
Cardiovascular illnesses are one of the leading causes of death universally. Though surgical and pharmacological involvements improve the quality of life of cardiac patients intensely, inexpensive and less invasive process are always more desirable. Biomaterials, both natural and synthetic, show great prospective in cardiac healing and rebirth. The use of injectable biomaterials results in reduced left ventricular dilatation, augmented angiogenesis, and safeguarding of cardiac function. The rising occurrence of cardiovascular illnesses is thus, anticipated to fuel biomaterials market growth during the projection period.
The biomedical burden of handling damaged or diseased organs endures to upsurge in parallel with the growing inhabitants. Variations of implantable devices are desired due to their recognised clinical efficacy and are presently being used as a framework for the reconstruction of soft or hard deficiencies. Additionally, they deal numerous benefits in wound healing uses. They help tissue development, preserve capacity and shape, and reduce the period of wound healing.
Comprehensive Analysis of Biomaterials Market
The market can be segmented in various ways, depending on the focus of analysis such as by materials, by application. Based on materials, the market is classified into metallic, ceramic, polymers, and natural biomaterials. Based on application, the market is segmented into cardiovascular, dental, orthopedic, plastic surgery, urology, gastroenterology, and others.
North America region is dominating the biomaterials market share due to high government funding in research and development, high occurrence of the cardiac diseases and orthopaedic alternatives.
The key players are enthusiastically contributing in planned events that are targeted at maintaining durable market position and growing market share by merger, partnerships and others. These players include Invibio Ltd (Washington), Wright Medical Technology, Inc. (United States), Evonik Industries AG (Germany), Zimmer Biomet (United States), DePuy Synthes Companies (United States), DSM Biomedical, Inc. (Netherlands), Corbion NV (Netherlands), Other Players these market players spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market.
In January 2021, Evonik made a declaration of the completion of its achievement with DURECT Corporation product line of LACTEL Absorbable Polymers. This achievement will complement company’s improvement growth field in healthcare solutions and will place a company as worldwide leader in incorporated CDMO for drug delivery.
Segmentation Table
ATTRIBUTE DETAILS
Study Period2016-2027
Base Year2019
Forecast Period2020-2027
Historical Period2016-2018
UnitValue (USD billion)
SegmentationBy Material
Metallic
Ceramic
Polymers
Natural
By Application
Cardiovascular
Dental
Orthopedic
Plastic Surgery
Urology
Gastroenterology
Others
By Geography
North America (the U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
Latin America (Brazil, Mexico, and the Rest of Latin America)
Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.